Download App

Log in to access Online Inquiry
Company Overview More
Tengsheng Boyao Biotechnology Co., Ltd. is a biotechnology company headquartered in China and the United States, mainly engaged in infectious disease therapy research and development business. The company's products are used in infectious diseases (such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacteria infections) and other diseases with significant public health burdens, such as central nervous system (CNS) diseases. The company also develops treatments for COVID-19 and others.
CEO: Zhi HONG
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

02137 BRII-B
8.200+0.100+1.23%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(FY)2019/12/31
Assets
Current assets
Advance deposits and other receivables
72.57% 58.88M -- 43.99M 618.47% 34.12M -- 4.75M
Cash and equivalents
175.86% 2.86B -- 1.44B 17.56% 1.03B -- 880.36M
Short-term deposit
2398.24% 499.65M -- -- -- 20M -- --
Secured deposit
-91.51% 319K -- 323K 976.5% 3.76M -- 349K
Total current assets
212.39% 3.41B -- 1.49B 23.42% 1.09B -- 885.46M
Non-current assets
Property, plant and equipment
-23.83% 12.57M -- 15.86M -22.63% 16.51M -- 21.33M
Advance payment
15.41% 2.79M -- 3.03M 4.19% 2.41M -- 2.32M
Financial assets at fair value-non-current assets
56.29% 117.79M -- 74.62M 3.54% 75.37M -- 72.79M
Intangible assets
-22.22% 9.51M -- 10.86M -- 12.22M -- --
Special items of non-current assets
-19.67% 55.1M -- 75.89M 19.23% 68.6M -- 57.53M
Total non-current assets
12.94% 197.76M -- 180.27M 13.73% 175.1M -- 153.97M
Total assets
184.85% 3.61B -- 1.67B 21.99% 1.27B -- 1.04B
Liabilities
Current liabilities
Other payables and accrued expenses
-56% 218.86M -- 117.19M 2709.16% 497.39M -- 17.71M
Financial lease liabilities-current liabilities
11.82% 8.97M -- 9.25M -0.61% 8.02M -- 8.07M
Deferred income-current liabilities
-24.26% 52.88M -- 26.8M 93.38% 69.82M -- 36.11M
Total current liabilities
-51.2% 280.71M -- 153.24M 829.54% 575.24M -- 61.88M
Net current assets
505.33% 3.13B -- 1.34B -37.15% 517.61M -- 823.57M
Total assets less current liabilities
380.86% 3.33B -- 1.52B -29.14% 692.71M -- 977.54M
Non-current liabilities
Financial lease liabilities-non-current liabilities
-37.72% 12.65M -- 18.17M -24.91% 20.31M -- 27.04M
Deferred income-non-current liabilities
-41.38% 7.08M -- 9.58M -56.72% 12.08M -- 27.92M
Special items of non-current liabilities
-- -- -- 6.13B 56.51% 2.4B -- 1.54B
Total non-current liabilities
-99.19% 19.73M -- 6.15B 53.14% 2.44B -- 1.59B
Total liabilities
-90.02% 300.44M -- 6.31B 82.22% 3.01B -- 1.65B
Total assets less total liabilities
290.01% 3.31B -- -4.64B -184.4% -1.74B -- -612.76M
Total equity and non-current liabilities
380.86% 3.33B -- 1.52B -29.14% 692.71M -- 977.54M
Equity
Share capital
228.57% 23K -- 7K 0% 7K -- 7K
Share premium
292.31% 3.34B -- -4.63B -183.68% -1.74B -- -612.77M
Shareholders' Equity
292.31% 3.34B -- -4.63B -183.68% -1.74B -- -612.76M
Non-controlling interest
-617.15% -31.65M -- -4.82M -- -4.41M -- --
Total equity
290.01% 3.31B -- -4.64B -184.4% -1.74B -- -612.76M
Total equity and total liabilities
184.85% 3.61B -- 1.67B 21.99% 1.27B -- 1.04B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor
Deloitte Guan Huang Chen Fang Accountants--Deloitte Guan Huang Chen Fang AccountantsDeloitte Guan Huang Chen Fang Accountants

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%